ep 459 has been researched along with leupeptins in 2 studies
| Studies (ep 459) | Trials (ep 459) | Recent Studies (post-2010) (ep 459) | Studies (leupeptins) | Trials (leupeptins) | Recent Studies (post-2010) (leupeptins) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 3,891 | 4 | 1,106 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishida, E; Ito, M; Sato, A; Shigeta, S; Takami, Y; Tanabe, F | 1 |
| Grinde, B | 1 |
2 other study(ies) available for ep 459 and leupeptins
| Article | Year |
|---|---|
The thiol proteinase inhibitors improve the abnormal rapid down-regulation of protein kinase C and the impaired natural killer cell activity in (Chediak-Higashi syndrome) beige mouse.
Topics: Animals; Calpain; Chediak-Higashi Syndrome; Cysteine Proteinase Inhibitors; Cytotoxicity, Immunologic; Disease Models, Animal; Killer Cells, Natural; Killer Factors, Yeast; Leucine; Leupeptins; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Protein Biosynthesis; Protein Kinase C; Proteins; Tetradecanoylphorbol Acetate | 1989 |
Selective inhibition of lysosomal protein degradation by the thiol proteinase inhibitors E-64, Ep-459 and Ep-457 in isolated rat hepatocytes.
Topics: Animals; Cysteine Endopeptidases; Drug Interactions; Kinetics; Leucine; Leupeptins; Liver; Lysosomes; Male; Propylamines; Protease Inhibitors; Rats; Rats, Inbred Strains | 1982 |